Related references
Note: Only part of the references are listed.Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis
Benjamin Ungar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers
Daphne S. Bakker et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study
Hidemi Nakagawa et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Claudin-1 decrease impacts epidermal barrier function in atopic dermatitis lesions dose-dependently
Sophia Bergmann et al.
SCIENTIFIC REPORTS (2020)
GPNMB is expressed in human epidermal keratinocytes but disappears in the vitiligo lesional skin
Kazal Boron Biswas et al.
SCIENTIFIC REPORTS (2020)
Tight Junction Structure and Function Revisited
Tetsuhisa Otani et al.
TRENDS IN CELL BIOLOGY (2020)
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis
Lisa Zhou et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
IFN-gamma Reduces Epidermal Barrier Function by Affecting Fatty Acid Composition of Ceramide in a Mouse Atopic Dermatitis Model
Hiroyuki Kanoh et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Early immunologic changes during the onset of atopic dermatitis
Patrick M. Brunner
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)
Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo
Meri K. Tulic et al.
NATURE COMMUNICATIONS (2019)
Antagonistic Effects of IL-4 on IL-17A-Mediated Enhancement of Epidermal Tight Junction Function
Matthew G. Brewer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Novel topical and systemic therapies in atopic dermatitis
Hiraku Suga et al.
IMMUNOLOGICAL MEDICINE (2019)
IL-33 down-regulates CLDN1 expression through the ERK/STAT3 pathway in keratinocytes
Woo-In Ryu et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2018)
Psoriasis pathogenesis and the development of novel targeted immune therapies
Jason E. Hawkes et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation
Achilleas Floudas et al.
JOURNAL OF IMMUNOLOGY (2017)
Dose-dependent role of claudin-1 in vivo in orchestrating features of atopic dermatitis
Reitaro Tokumasu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17
Takuo Yuki et al.
PLOS ONE (2016)
Diverse Regulation of Claudin-1 and Claudin-4 in Atopic Dermatitis
Robert Gruber et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Interferon-γ Decreases Ceramides with Long-Chain Fatty Acids: Possible Involvement in Atopic Dermatitis and Psoriasis
Chisato Tawada et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Skin Barrier and Immune Dysregulation in Atopic Dermatitis: An Evolving Story with Important Clinical Implications
Tali Czarnowicki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)
Impaired tight junctions obstruct stratum corneum formation by altering polar lipid and profilaggrin processing
Takuo Yuki et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2013)
Tight junction dysfunction in the stratum granulosum leads to aberrant stratum corneum barrier function in claudin-1-deficient mice
Tomoko Sugawara et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2013)
Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice
Yasutomo Imai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion
Danuta Gutowska-Owsiak et al.
EXPERIMENTAL DERMATOLOGY (2012)
Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis
Julia K. Gittler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Regulation of IL-33 Expression by IFN-γ and Tumor Necrosis Factor-α in Normal Human Epidermal Keratinocytes
Jitlada Meephansan et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Brodalumab, an Anti-Interleukin-17-Receptor Antibody for Psoriasis
Kim A. Papp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Activation of TLR2 Enhances Tight Junction Barrier in Epidermal Keratinocytes
Takuo Yuki et al.
JOURNAL OF IMMUNOLOGY (2011)
Characterization of Tight Junctions and Their Disruption by UVB in Human Epidermis and Cultured Keratinocytes
Takuo Yuki et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Extrinsic and intrinsic types of atopic dermatitis
Yoshiki Tokura
JOURNAL OF DERMATOLOGICAL SCIENCE (2010)
Epidermal Permeability Barrier Recovery Is Delayed in Vitiligo-Involved Sites
J. Liu et al.
SKIN PHARMACOLOGY AND PHYSIOLOGY (2010)
Zonula Occludens-1 and-2 Are Cytosolic Scaffolds That Regulate the Assembly of Cellular Junctions
Alan S. Fanning et al.
MOLECULAR STRUCTURE AND FUNCTION OF THE TIGHT JUNCTION: FROM BASIC MECHANISMS TO CLINICAL MANIFESTATIONS (2009)
The skin: an indispensable barrier
Ehrhardt Proksch et al.
EXPERIMENTAL DERMATOLOGY (2008)
Tight junction proteins in keratinocytes: localization and contribution to barrier function
Takuo Yuki et al.
EXPERIMENTAL DERMATOLOGY (2007)
Claudins in occluding junctions of humans and flies
M Furuse et al.
TRENDS IN CELL BIOLOGY (2006)
Organization and formation of the tight junction system in human epidermis and cultured keratinocytes
JM Brandner et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2002)
Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice
M Furuse et al.
JOURNAL OF CELL BIOLOGY (2002)
Share Paper
